Status:

COMPLETED

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Lead Sponsor:

Exact Sciences Corporation

Conditions:

Colorectal Cancer

Eligibility:

All Genders

40+ years

Brief Summary

The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays f...

Detailed Description

Participants will be 40 years of age or older, with a diagnosis of CRC, at any stage, confirmed with a tissue biopsy or a colorectal lesion at least 1 cm in size suspicious for adenoma (including sess...

Eligibility Criteria

Inclusion

  • Participant is 40 years of age or older.
  • Participant has a diagnosis of CRC, at any stage, confirmed with a tissue biopsy or a colorectal lesion at least 1 cm in size suspicious for adenoma (including sessile serrated adenoma) or CRC on a pre-enrollment colonoscopy, sigmoidoscopy, or CT colonography.
  • Postcolonoscopy, the residual lesion in the colon must be at least 1 cm in size as to require additional surgical excision or complex colonoscopic polypectomy.
  • Participant understands the study procedures and is able to provide informed consent to take part in the study and authorization for release of relevant protected health information to the study Investigator.

Exclusion

  • Any previous cancer diagnosis (with the exceptions of basal cell or squamous cell skin cancers) and/or cancer related treatment (e.g., chemotherapy, immunotherapy, radiation, and/or surgery) within the past 5 years.
  • Less than 7 days between colonoscopy and blood and/or stool specimen collection.
  • IV contrast (e.g., CT or MRI) within 1 day \[or 24 hours\] before blood and/or stool collection.
  • Participant has any condition that in the opinion of the Investigator should preclude taking part in the study.

Key Trial Info

Start Date :

December 20 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 29 2025

Estimated Enrollment :

850 Patients enrolled

Trial Details

Trial ID

NCT03789162

Start Date

December 20 2018

End Date

May 29 2025

Last Update

June 29 2025

Active Locations (45)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (45 locations)

1

Mayo Clinic - Arizona

Phoenix, Arizona, United States, 85054

2

Alliance Research Institute

Canoga Park, California, United States, 91304

3

GW Research Inc

Chula Vista, California, United States, 91910

4

Tilda Research

Laguna Hills, California, United States, 92653